Automating Tobacco Cessation in Primary Care

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Pennsylvania

About this trial

This study focuses on improving how primary care teams identify patients who smoke and offer access to nicotine replacement therapy, or NRT. NRT includes medications such as nicotine patches, gum, or lozenges that can reduce cravings and support people who are interested in cutting back or quitting smoking. Although NRT is an evidence-based treatment option, it is not always discussed or prescribed during routine primary care visits. To better understand how NRT can be offered in primary care, the project will test a workflow at Penn Family Care that identifies patients who currently smoke and provides information about available tobacco treatment options. Edward Cooper Internal Medicine will serve as a comparison site. Patients who smoke and/or are prescribed NRT will also receive a 30-day follow-up survey to learn whether they received, picked up, or used NRT; whether it was useful; and what barriers they experienced.

Eligibility criteria

Qualifiers

Age 18 years or older

Patient at Penn Family Care or Edward Cooper Internal Medicine

Had an eligible scheduled or completed practice visit categorized as a new annual visit, return patient visit, return annual visit, or return patient sick visit

For the tobacco cessation intervention: Penn Family Care patient who had not previously completed the tobacco questionnaire

Disqualifiers

None except as specified in inclusion criteria.

Trial design

Treatments tested in this trial

  • Tobacco counseling resources

Treatment groups

4,800 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators